What are the signs and symptoms of Intrahepatic Cholestasis of Pregnancy (ICP)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Signs and Symptoms of Intrahepatic Cholestasis of Pregnancy (ICP)

Intrahepatic cholestasis of pregnancy (ICP) is primarily characterized by pruritus (itching) without a rash that typically occurs in the second and third trimesters of pregnancy, accompanied by elevated serum bile acid levels. 1

Primary Clinical Manifestations

Pruritus (Key Diagnostic Feature)

  • Generalized itching but predominantly affects the palms and soles of the feet 1
  • Typically worse at night 1
  • Usually not associated with a primary rash, though excoriations from scratching may be present 1
  • Often the first and most troublesome symptom 2

Laboratory Abnormalities

  • Elevated serum bile acid levels (≥10 μmol/L) 2
  • Elevated liver transaminases (ALT, AST) may be present but not necessary for diagnosis 1
  • Bile acid levels are the most sensitive indicator and may precede other abnormal liver tests 1

Risk Stratification Based on Bile Acid Levels

  • 10 μmol/L: Diagnostic threshold for ICP 2

  • 40 μmol/L: Increased risk of adverse pregnancy outcomes 2

  • ≥100 μmol/L: Significantly increased risk of stillbirth after 35 weeks gestation 2

Less Common Symptoms and Signs

  • Excoriations or prurigo nodularis from intense scratching (may be mistaken for a rash) 1
  • Steatorrhea (infrequent) 1
  • Jaundice is uncommon and suggests other hepatic diseases 1
  • Dark urine is uncommon and suggests other hepatic diseases 1

Important Negative Findings

  • Absence of primary rash (distinguishes ICP from other pruritic conditions of pregnancy) 1
  • Excessive fatigue, insomnia, malaise, and abdominal pain/colic are not common with ICP 1
  • If these symptoms are present, evaluation for other causes of pruritus and hepatic disease may be warranted 1

Timing and Course

  • Typically occurs in the second and third trimesters 1, 2
  • Early-onset ICP (before 33 weeks) may be associated with increased fetal complications 1
  • Symptoms spontaneously resolve within 4-6 weeks after delivery 1

Clinical Pearls

  • ICP has a recurrence rate of 45-90% in subsequent pregnancies 3
  • Patients with genetic variants in hepatobiliary transport proteins (particularly ABCB4 and ABCB11) may present with earlier onset or more severe disease 4
  • ICP is more common in multiple pregnancies due to higher hormonal levels 1

Differential Diagnosis Considerations

When evaluating a pregnant woman with pruritus, consider:

  • Atopic eruption of pregnancy (AEP) - associated with eczematous rash 1
  • Polymorphic eruption of pregnancy (PEP) - associated with urticarial papules and plaques 1
  • Pemphigoid gestationis (PG) - associated with vesicles and bullae 1
  • Other causes of pruritus without rash (renal failure, thyroid disorders, other liver diseases) 1

Remember that while maternal outcomes are generally benign, ICP is associated with increased risk of adverse fetal outcomes including preterm delivery, meconium staining, and stillbirth, making prompt diagnosis and management essential 1, 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Intrahepatic Cholestasis of Pregnancy (ICP) Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.